Skip Navigation

Legislative Priorities

IPA's Ongoing Advocacy Efforts

IPA seeks to educate policymakers on the value of the pharmacy profession across the continuum of healthcare, and to work toward maximizing the pharmacist, pharmacy intern and pharmacy technician's role in the delivery of patient care services to improve patient safety and health outcomes in Indiana.  Some of IPA's ongoing priorities are listed below. 

 

Click here to donate to IPA's Political Action Committee.

 

Indiana Legislative Agenda

  • Reimbursement for Pharmacy Services - Educate policy makers on the public health contributions of pharmacists through broadened pharmacy services, and secure reimbursement for scope of practice services that are identical to healthcare peers

  • Pharmacy Benefit Manager (PBM) Practices - Educate policymakers on current healthcare reimbursement models and work to promote fair business principles by promoting legislation that addresses issues such as prescription drug pricing and reimbursement, fair audit practices, mandatory mail-order programs, and PBM transparency.

  • Opioid Crisis - Work with stakeholders to create and enforce effective public health policy, including the implementation of utilization and reporting methods that decrease diversion and keep patients safe, while also maintaining access to medications for appropriate use.

  • Immunizations - Work with stakeholders to ensure that patients have access to immunizations. Additionally, educate policy makers on the importance of pharmacy professionals in providing accessibility to vaccinations in the community.

  • Medication safety - Educate policymakers on methods for promoting and supporting a culture of safe medication use while emphasizing the potential healthcare risks that arise when medication errors are not reported due to a punitive culture.

If you have any recommendations or questions, please contact:

• Darren Covington, Executive Vice President, 317-634-4968, or Darren@IndianaPharmacists.org

• Veronica Vernon, Chair, Legislative & Regulatory Council, 765-586-6181, or vvernon@butler.edu

  • Ryan Ades, Vice-Chair, Legislative & Regulatory Council, 419-571-8092, or rades@manchester.edu

 

Federal Legislative Agenda

  • Direct and Indirect Renumeration (DIR) Fees - Support national efforts to limit the inappropriate use of DIR fees as a method of recouping dollars from pharmacies after a claim has been adjudicated.

  • Provider Status - Work with national organizations and pharmacy stakeholders to support patient access to pharmacy services through initiatives that recognize pharmacists as providers under Medicare Part B.

  • Reimbursement - Support national efforts to improve the frequency and accuracy of drug pricing standards, expand upon Medicare’s any willing pharmacy provisions, and increase transparency requirements for PBMs.